This Article Full Text Full Text (PDF) All Versions of this Article: 107/22/2810    most recent 01.CIR.0000070949.76608.E2v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Lipsanen-Nyman, M. Articles by Kupari, M. Search for Related Content PubMed PubMed Citation Articles by Lipsanen-Nyman, M. Articles by Kupari, M. Related Collections Clinical genetics Congestive Pericardial disease Myocardial cardiomyopathy disease

(Circulation. 2003;107:2810.)
© 2003 American Heart Association, Inc.

Clinical Investigation and Reports

Mulibrey Heart Disease

Clinical Manifestations, Long-Term Course, and Results of Pericardiectomy in a Series of 49 Patients Born Before 1985

Marita Lipsanen-Nyman, MD; Jaakko Perheentupa, MD; Juhani Rapola, MD; Anssi Sovijärvi, MD; Markku Kupari, MD

From the Hospital for Children and Adolescents (M.L.-N., J.P., J.R.), the Department of Clinical Physiology and Nuclear Medicin (A.S.) and the Department of Cardiology (M.K.), Helsinki University Central Hospital, Helsinki, Finland.

Correspondence to Dr Markku Kupari, Cardiovascular Laboratory, Helsinki University Central Hospital, 00029 HUS, Finland. E-mail markku.kupari{at}hus.fi

Background— Mulibrey nanism is a rare inherited disease characterized by growth failure and multiorgan manifestations, including constrictive pericarditis. Its long-term course, the results of pericardiectomy, and the details of myocardial involvement have not been reported previously.

Methods and Results— We studied 49 patients (26 men) born before 1985 and followed for up to 25 years. By 1999, 25 patients (51%) had developed congestive heart failure (CHF), 19 (39%) had undergone pericardiectomy for constrictive pericarditis, 10 (22%) had died of cardiac causes, and 5 (10%) had died of noncardiac causes. Of the 19 pericardiectomized patients, 12 derived lasting clinical benefit, whereas 1 patient suffered an early noncardiac death and 6 died later of unrelieved or recurrent CHF. At echocardiography in 34 living patients, left ventricular mass adjusted for body height and weight averaged (±SEM) 149±5 g in 21 unoperated patients, 144±8 g in 13 pericardiectomized patients, and 104±7 g in 16 healthy persons matched for age and sex (P=0.000). Autopsies of 11 patients showed fibrotic thickening of the pericardial leaves with myocardial hypertrophy and variable but mostly mild myocardial fibrosis. Endocardial thickening was seen in 3 patients.

Conclusions— Constrictive pericarditis, myocardial hypertrophy, and variable myocardial fibrosis constitute the main elements of Mulibrey heart disease. At least one half of patients ultimately develop CHF. Pericardiectomy generally provides clinical benefit, but in approximately one third of patients, CHF may recur because of coexisting myocardial involvement.

Key Words: pericardium • myocardium • heart failure • surgery

This article has been cited by other articles:

				N. Karlberg, H. Jalanko, and M. Lipsanen-Nyman Growth and Growth Hormone Therapy in Subjects With Mulibrey Nanism Pediatrics, July 1, 2007; 120(1): e102 - e111. [Abstract] [Full Text] [PDF]

				N. Karlberg, H. Jalanko, J. Kallijarvi, A.-E. Lehesjoki, and M. Lipsanen-Nyman Insulin Resistance Syndrome in Subjects With Mutated RING Finger Protein TRIM37 Diabetes, December 1, 2005; 54(12): 3577 - 3581. [Abstract] [Full Text] [PDF]

				N Karlberg, H Jalanko, J Perheentupa, and M Lipsanen-Nyman Mulibrey nanism: clinical features and diagnostic criteria J. Med. Genet., February 1, 2004; 41(2): 92 - 98. [Abstract] [Full Text] [PDF]